MNGA is a big target now that the company is recording sale after sale for its MagneGas®. Surely this is the catalyst for the 64 RSI stock that is currently in breakout mode?
ARQL has been my worst play this year… I almost threw in the towel until I came across Ultimate Stock Alerts (you can find them in Google)
Lets say the stock went up because of a Zack's report and a company presentation (i.e. fluff). Expect the price to now drift back down.
And by the way, there are red flags: 1) no research papers, poster boards, yes there is a difference. 2) one outside research paper that says tivantinib has other than intended actions 3) prior promising applications have failed in clinical trials. The dilemma: chemotherapy usually targets cancer cells via their rapid growth. Adding a growth inhibitor to the mix seems illogical. Likely it could be a useful agent, given a plausible working strategy. Other products are a ways off. Good luck!
MNGA is now front page news thanks to an order for its MagneGas® gas as a replacement for acetylene. This is the news investors have been waiting for without a doubt.
Apparently many of you were easily fooled into thinking that in order for me to adore you, you had to get me upset somehow... well, surprise surprise, that is the furthest away from the truth. So, I would like a fresh start by you thinking outside the box and express how you truly feel towards me, as I most likely feel the same towards you.
It is a couple of things. The market is down last couple of days. This is $2.00 biotech stock, so the least little bit of news will make it drop. There must be more $2.00 stocks that claims they are the next Biogene to only end up doing a 1-100 reverse stock split, then the results don't pan out, pink sheets and then bankruptcy. Not saying this is necessarily the case with this stock, however, these $2.00 stocks usually follow the path I just described. Hope you success if you invested in this stock.